| Net Loss Per Share Attributable to Common Stockholders |
Net Loss Per Share Attributable to Common Stockholders The following table sets forth the calculation of basic and diluted net loss per share attributable to common stockholders during the three months ended March 31, 2026 and 2025: | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | | 2026 | | 2025 | | | | | | | | | | | | | | Net loss attributable to Nuvve Holding Corp. common stockholders | $ | (5,834,219) | | | $ | (6,873,003) | | | | | | | Weighted-average shares used to compute net loss per share attributable to Nuvve common stockholders, basic and diluted | 201,488 | | | 2,461 | | | | | | | Net Loss per share attributable to Nuvve common stockholders, basic and diluted | $ | (28.96) | | | $ | (2,792.31) | | | | | |
The following outstanding shares of common stock equivalents were excluded from the calculation of the diluted net loss per share attributable to Nuvve common stockholders because their effect would have been anti-dilutive: | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | | 2026 | | 2025 | | | | | | Stock options issued and outstanding | 10,478 | | 9 | | | | | | | Nonvested restricted stock issued and outstanding | — | | | — | | | | | | | Public warrants | — | | | 10 | | | | | | | Private warrants - February 2020 | — | | | — | | | | | | | | | | | | | | | PIPE warrants | — | | | 5 | | | | | | | | | | | | | | | | | | | | | | | 2022 July Institutional/Accredited Investor Warrants | 14 | | | 14 | | | | | | | | | | | | | | | Underwriter Warrant - February 2024 offering | 36 | | | 35 | | | | | | | 2024 February Institutional/Accredited Investor Warrants - series A | 667 | | | 667 | | | | | | | | | | | | | | | 2024 February Institutional/Accredited Investor Warrants - series C | 42 | | | 42 | | | | | | | 2024 October Institutional/Accredited Investor Warrants | 1,436 | | | 1,594 | | | | | | | 2024 December Institutional/Accredited Investor Warrants | — | | | 118 | | | | | | | 2025 March Institutional/Accredited Investor Warrants | — | | | 1,146 | | | | | | | | | | | | | | | 2025 May Institutional/Accredited Investor Warrants | 28,544 | | | — | | | | | | | | | | | | | | | 2025 July Institutional/Accredited Investor Warrants | 402 | | | — | | | | | | | 2025 September Institutional/Accredited Investor Warrants | 5,465 | | | — | | | | | | | 2025 November Institutional/Accredited Investor Warrants | 13,663 | | | — | | | | | | | 2025 December 17, Institutional/Accredited Investor Warrants | 5,465 | | | — | | | | | | | 2025 December 26 Institutional/Accredited Investor Warrants | 5,465 | | | — | | | | | | | 2025 December 30 Institutional/Accredited Investor Warrants | 140,825 | | | — | | | | | | | 2025 December Institutional/Accredited Investor Pre-Funded Warrants | 1,543 | | | — | | | | | | | 2026 January Institutional/Accredited Investor Warrants | 12,387 | | | — | | | | | | | 2026 February Institutional/Accredited Investor Warrants | 13,663 | | | — | | | | | | | 2026 March 6 Institutional/Accredited Investor Warrants | 16,943 | | | — | | | | | | | 2026 March 27 Institutional/Accredited Investor Warrants | 98,138 | | | — | | | | | | | May 2025 Consulting Warrants | 12,500 | | | — | | | | | | | May 2025 Consulting Warrants | 2,778 | | | — | | | | | | | Convertible preferred stock | 134,364 | | | — | | | | | | | Convertible notes payable | 21,593 | | | — | | | | | | | Total | 526,411 | | 3,640 | | | | | | | | | | | | |
|